P2Y12 inhibitor

P2Y12 receptor inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P2Y12 inhibitor, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury [Phase 2, Phase 3]